Please assess the completion status of the following clinical trial:

Trial Title: Outpatient Foley Catheter Compared to Usual Inpatient Care for Labor Induction

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria~1. Pregnant women at ≥37 weeks gestation by reliable dating criteria as determined by the American College of Obstetricians and Gynecologists (i.e. gestational age supported by one of the following: ultrasound prior to 20 weeks of gestation, fetal heart tones auscultated by Doppler for 30+ weeks, or documented serum or urine pregnancy test 36+ weeks ago)~2. Scheduled induction of labor with indication and timing supported by the Family Birth Center induction of labor guideline entitled Induction of labor: Indications and Timing~3. Singleton gestation~4. Cephalic presentation~5. Amniotic fluid index greater than or equal to 5 centimeters~6. Formal prenatal ultrasound documenting the absence of placenta previa~7. Bishop score \<6 and cervical dilation \<3cm~8. The woman is able to give appropriate consent and has undergone an informed consent process.~9. Maternal age ≥ 18 years old at the time of consent.~Exclusion Criteria~1. New diagnosis requiring immediate hospitalization for monitoring (such as new onset hypertensive disease of pregnancy)~2. Vaginal bleeding~3. Active labor~4. Premature rupture of membranes as determined by positive ferning and as supported by pooling of fluid in the vaginal vault.~5. Uterine tachysystole (\>5 contractions in 10 minutes)~6. Nonreassuring fetal heart tracing before or after Foley placement~7. Chorioamnionitis or maternal fever~8. Intrauterine fetal demise~9. Contraindication to vaginal delivery, relative or absolute (i.e. transfundal uterine surgery)~10. Abnormal placentation including a low lying placenta~11. Prior cesarean delivery~12. Intrauterine growth restriction (growth \<10th percentile by formal ultrasound)~13. Known fetal anomaly~14. Human immunodeficiency virus, Hepatitis C, or active herpes infection~15. Maternal cardiopulmonary disease requiring cardiac monitoring during labor~16. Pregestational diabetes~17. Rh isoimmunization~18. Non-English speaking~19. Distance from the hospital over 60 minutes by car, unreliable communication via telephone, or unreliable transportation

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Outpatient Foley catheter (Randomized & Prospective) (Type: EXPERIMENTAL): This arm reflects enrolled women who were (A) randomized to the outpatient Foley catheter group (RCT design) or (B) chose the outpatient Foley catheter group (Modified Prospective study design).~Participants underwent basic history review, fetal nonstress testing, ultrasound for presentation and amniotic fluid index, and cervical exams the evening before their scheduled induction in the Family Birth Center. A Foley catheter was placed for cervical ripening. After fetal monitoring, they were dismissed to home, to return to the Family Birth Center in the morning for continuation of their labor inductions in the inpatient setting.
- Inpatient usual care (Randomized & Prospective) (Type: ACTIVE_COMPARATOR): This arm reflects enrolled women who were (A) randomized to the inpatient usual care group (RCT design) or (B) chose the inpatient usual care group (Modified Prospective study design). No participants in the modified Prospective study design were accrued due to screen failure.~Participants presented to the Family Birth Center in the evening for their scheduled induction of labor. They underwent basic history review, fetal nonstress testing, ultrasound for presentation and amniotic fluid index, and cervical exam. Cervical ripening commenced with either a Foley catheter or vaginal misoprostol per the discretion of the managing obstetric team. They remained in the inpatient setting throughout their entire labor induction course.

Based on this trial design, predict the completion outcome and termination type (if applicable).